News
Medtronic's decade-long underperformance stems from stagnant revenue growth, declining margins, and inconsistent returns on ...
If you're looking for high-yield stocks in the healthcare sector, it's hard to beat this trio of industry giants offering ...
Medtronic partnered with InStride to design customized skills-based opportunities for workers, offering over 800 pathways to ...
Medtronic (NYSE:MDT) shares snapped six straight sessions of gains, as the stock was down 1% at $91.99 on Monday.
The company showcases solid financial health with steady revenue, strong free cash flow, and reliable earnings.
3d
Medical Device Network on MSNMedtronic’s INFUSE Bone Graft trial meets predefined early success criteriaMedtronic has announced that an independent Data Monitoring Committee (DMC) reviewed the initial interim analysis and ...
Holton was a graduate student in her early 20s when she lost her own mother to metastatic breast cancer. The experience left ...
The stock's fall snapped a six-day winning streak.
2d
Zacks.com on MSNMedtronic (MDT) Stock Sinks As Market Gains: What You Should KnowIn the latest trading session, Medtronic (MDT) closed at $91.97, marking a -1.04% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.02% for the day. At the ...
We came across a bullish thesis on Medtronic plc on Max Dividends’s Substack. In this article, we will summarize the bulls’ ...
A U.S. appeals court on Friday overturned a jury's verdict that medical device maker Medtronic owes competitor Colibri $106.5 ...
TOKYO -- Medtronic, the world's largest medical device maker, is considering investment in Japanese startups in areas such as artificial intelligence, citing improved "clarity" on the global economic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results